Clinical Trial Update: Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial updating strategies to prevent nephrotoxicity and ototoxicity in osteosarcoma therapy; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotoxicity
• Osteosarcoma
• Ototoxicity

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Osteosarcoma, Nephrotoxicity | Phase 2 | Status: COMPLETED | Results posted: 2020-03-16